Click Here
Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  Pharmaceutical Technology Europe E-Alert
 
JUNE 26, 2009
IN THIS ISSUE
EFCG guidelines
Biotechnology in 2014
PTE on LinkedIn
EMEA's transparency
More...

Click Here

EFCG launches new guidelines compliance tool
Following the 2008 launch of the European Fine Chemicals Group (EFCG) Voluntary Guidelines (VGs) to promote supply chain security, the group has now announced the official launch of an assessment template that will allow fine chemicals customers and suppliers to assess and implement this new set of recommendations. More...

Will biotech rule pharma's world in 2014?
According to market analysis firm EvaluatePharma, the top six selling drugs of 2014 are all expected to be biotech products compared with only five in 2008 and one in 2000. More...

Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...

EMEA launches public consultation on new transparency policy
The European Medicines Agency (EMEA) is inviting comments on its draft transparency policy. More...

Big Pharma to donate swine flu vaccines
Sanofi-aventis will donate 100 million doses of vaccine against the pandemic H1N1 2009 virus to the World Health Organization (WHO). More...

Swine flu vaccine manufacture underway
Protein Sciences Corp (CT, USA) is one of the latest companies to join the H1N1 influenza vaccine race after initiating manufacture of its vaccine PanBlok, which is made using the company's baculovirus and insect cell manufacturing technology. More...

Vetter claims success with new facility
Vetter has completed the installation of six automatic packaging lines at its new packaging services facility in Ravensburg (Germany). More...

FDA approves first macular oedema drug therapy
The FDA has approved the first drug therapy for the treatment of macular oedema following branch retinal vein occlusion or central retinal vein occlusion, which is a significant cause of vision loss. More...

Key Topic Updates
July events
The Scale-Up of Chemical Processes (Canada)
ISSCR 7th Annual Meeting (Spain)
GMP in the laboratory (UK)
Submit your event
 
Biopharmaceuticals articles
New expression systems create opportunities for innovators, CMOs and product developers
Upcoming technologies to facilitate more efficient biologics manufacturing
PAT: HPLC on the horizon?
More Biopharmaceuticals articles
 
Information technology articles
Elevating laboratory informatics to assist decision-making
Efficient logistic operations
Proactive protection
More information technology articles

Key Topic Updates

Survey
A new law would give Europeans the right to seek healthcare abroad more easily. Does this risk putting medical tourism before universal access to quality domestic healthcare?
  Yes 44%
  No 26%
  Only time will tell 30%

This week we would like to know...

What type of pharma news are you most interested in?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.


You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.